Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1985 Feb;201(2):210–218. doi: 10.1097/00000658-198502000-00013

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival.

D A August, P H Sugarbaker, R T Ottow, F J Gianola, P D Schneider
PMCID: PMC1250643  PMID: 3970602

Abstract

This report analyzes an experience with 33 hepatic resections for metastatic colorectal cancer over a 7-year period and with intraperitoneal 5-FU administered as a postresection adjuvant in 21 of these patients. Particular emphasis is placed on the identification of clinical determinants of postresection survival. There was no operative mortality in this series. Postoperative complications occurred in 27% of patients, and the incidence of complications correlated with intraoperative blood loss (p = 0.002). Two- and 4-year estimated survivals were 72% and 53%, respectively. Patients with three or fewer metastases resected or with unilobar disease had improved survival when compared with patients having more than three metastases or bilobar disease, respectively (p less than 0.05). Disease-free survival was improved in patients with microscopically negative resection margins (p = 0.019). Dukes' stage of the primary lesion, interval between bowel resection and detection of hepatic metastases, method of detection of metastases, preoperative CEA level, and type of operation performed were not predictive of postresection survival. Intraperitoneal 5-FU was well tolerated. There was a trend toward improved survival in patients receiving adjuvant chemotherapy, but this was not statistically significant. It is concluded that the number of metastases resected, the distribution of the metastases, and the technical adequacy of the excision are all predictive of outcome following hepatic resection of colorectal metastases. Encouraging results with the use of intraperitoneal 5-FU as a postresection adjuvant have led to the initiation of a prospective randomized trial investigating this modality at the NCI.

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTLER V. B., COLLER F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954 Jun;139(6):846–852. doi: 10.1097/00000658-195406000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adson M. A. Hepatic metastases in perspective. AJR Am J Roentgenol. 1983 Apr;140(4):695–700. doi: 10.2214/ajr.140.4.695. [DOI] [PubMed] [Google Scholar]
  3. Adson M. A., Van Heerden J. A. Major hepatic resections for metastatic colorectal cancer. Ann Surg. 1980 May;191(5):576–583. doi: 10.1097/00000658-198005000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Attiyeh F. F., Wanebo H. J., Stearns M. W. Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum. 1978 Apr;21(3):160–162. doi: 10.1007/BF02586558. [DOI] [PubMed] [Google Scholar]
  5. Baden H., Andersen B. Survival of patients with untreated liver metastases from colorectal cancer. Scand J Gastroenterol. 1975;10(2):221–223. [PubMed] [Google Scholar]
  6. Bengmark S., Hafström L., Jeppsson B., Jönsson P. E., Rydén S., Sundqvist K. Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgery. World J Surg. 1982 Jan;6(1):61–65. doi: 10.1007/BF01656374. [DOI] [PubMed] [Google Scholar]
  7. Dedrick R. L., Myers C. E., Bungay P. M., DeVita V. T., Jr Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978 Jan;62(1):1–11. [PubMed] [Google Scholar]
  8. Fortner J. G., Silva J. S., Golbey R. B., Cox E. B., Maclean B. J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984 Mar;199(3):306–316. doi: 10.1097/00000658-198403000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Foster J. H., Lundy J. Liver Metastases. Curr Probl Surg. 1981 Mar;18(3):157–202. doi: 10.1016/s0011-3840(81)80009-3. [DOI] [PubMed] [Google Scholar]
  10. Goslin R., Steele G., Jr, Zamcheck N., Mayer R., MacIntyre J. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum. 1982 Nov-Dec;25(8):749–754. doi: 10.1007/BF02553304. [DOI] [PubMed] [Google Scholar]
  11. Iwatsuki S., Shaw B. W., Jr, Starzl T. E. Experience with 150 liver resections. Ann Surg. 1983 Mar;197(3):247–253. doi: 10.1097/00000658-198303000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jenkins J., Sugarbaker P. H., Gianola F. J., Myers C. E. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet. 1982 Jun;154(6):858–862. [PubMed] [Google Scholar]
  13. Keen W. W. IV. Report of a Case of Resection of the Liver for the Removal of a Neoplasm, with a Table of Seventy-six Cases of Resection of the Liver for Hepatic Tumors. Ann Surg. 1899 Sep;30(3):267–283. doi: 10.1097/00000658-189907000-00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kortz W. J., Meyers W. C., Hanks J. B., Schirmer B. D., Jones R. S. Hepatic resection for metastatic cancer. Ann Surg. 1984 Feb;199(2):182–186. doi: 10.1097/00000658-198402000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lahr C. J., Soong S. J., Cloud G., Smith J. W., Urist M. M., Balch C. M. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol. 1983 Nov;1(11):720–726. doi: 10.1200/JCO.1983.1.11.720. [DOI] [PubMed] [Google Scholar]
  16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  17. Miller D. L., Rosenbaum R. C., Sugarbaker P. H., Vermess M., Willis M., Doppman J. L. Detection of hepatic metastases: comparison of EOE-13 computed tomography and scintigraphy. AJR Am J Roentgenol. 1983 Nov;141(5):931–935. doi: 10.2214/ajr.141.5.931. [DOI] [PubMed] [Google Scholar]
  18. Morrow C. E., Grage T. B., Sutherland D. E., Najarian J. S. Hepatic resection for secondary neoplasms. Surgery. 1982 Oct;92(4):610–614. [PubMed] [Google Scholar]
  19. Nims T. A. Resection of the liver for metastatic cancer. Surg Gynecol Obstet. 1984 Jan;158(1):46–48. [PubMed] [Google Scholar]
  20. Rajpal S., Dasmahapatra K. S., Ledesma E. J., Mittelman A. Extensive resections of isolated metastasis from carcinoma of the colon and rectum. Surg Gynecol Obstet. 1982 Dec;155(6):813–816. [PubMed] [Google Scholar]
  21. Speyer J. L., Myers C. E. The use of peritoneal dialysis for delivery of chemotherapy to intraperitoneal malignancies. Recent Results Cancer Res. 1980;74:264–269. doi: 10.1007/978-3-642-81488-4_31. [DOI] [PubMed] [Google Scholar]
  22. Speyer J. L., Sugarbaker P. H., Collins J. M., Dedrick R. L., Klecker R. W., Jr, Myers C. E. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res. 1981 May;41(5):1916–1922. [PubMed] [Google Scholar]
  23. Thompson H. H., Tompkins R. K., Longmire W. P., Jr Major hepatic resection. A 25-year experience. Ann Surg. 1983 Apr;197(4):375–388. doi: 10.1097/00000658-198304000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vermess M., Doppman J. L., Sugarbaker P. H., Fisher R. I., O'Leary T. J., Chatterji D. C., Grimes G., Adamson R. H., Willis M., Edwards B. K. Computed tomography of the liver and spleen with intravenous lipoid contrast material: review of 60 examinations. AJR Am J Roentgenol. 1982 Jun;138(6):1063–1071. doi: 10.2214/ajr.138.6.1063. [DOI] [PubMed] [Google Scholar]
  25. Wilson S. M., Adson M. A. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg. 1976 Apr;111(4):330–334. doi: 10.1001/archsurg.1976.01360220026004. [DOI] [PubMed] [Google Scholar]
  26. Wood C. B., Gillis C. R., Blumgart L. H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976 Sep;2(3):285–288. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES